Fast Five Quiz: Menopause

Richard Scott Lucidi, MD, FACOG


June 24, 2022

Vasomotor symptom may affect the quality of life for symptomatic menopausal women. Although hormone therapy is the mainstay of treatment, it is not the best option for menopausal women with vasomotor symptoms who have contraindications or prefer to avoid hormonal therapies. Multiple clinical trials have demonstrated significant reductions in both the severity and frequency of hot flashes with the use of SSRIs. Currently, the only FDA-approved nonhormonal medication for the management of vasomotor symptoms is paroxetine.

Learn more about menopause.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.